Effect of HIV on liver fibrosis among HCV-infected African Americans

Clinical Infectious Diseases

Volumn 56, Issue 9, 2013, Pages 1280-1283

  Silver, D ^a   Karnik, G ^b   Osinusi, A ^b   Silk, R ^b   Stabinski, L ^c   Doonquah, L ^d   Henn, S ^e   Teferi, G ^f   Masur, H ^a   Kottilil, S ^c   Fishbein, D ^b,g  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b SAIC FREDERICK INC   (United States)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^d Family and Medical Counseling Service   (United States)

^e Whitman Walker Health ^*  (United States)

^f Unity Health Care   (United States)

^g WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

African Americans; HCV; HIV; liver fibrosis

Indexed keywords

ADULT; AFRICAN AMERICAN; ARTICLE; BODY MASS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER BIOPSY; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; AFRICAN AMERICANS; AGED; COINFECTION; FEMALE; HEPATITIS C, CHRONIC; HIV INFECTIONS; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84875993313     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cit037     Document Type: Article

References (14)

1. Alter M. Epidemiology of hepatitis C virus infection. World J Gastroenterol 2007; 13:2436-41. (Pubitemid 46929498)
2. Maier IWG. Hepatitis C and HIV co-infection: a review. World J Gastroenterol 2002; 8:577-9.
3. Pearlman BL. Hepatitis C virus infection in African Americans. Clin Infect Dis 2006; 42:82-91. (Pubitemid 41832084)
4. Lewden C, Salmon D, Morlat P, et al. Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: emerging role of hepatitis and cancers, persistent role of AIDS. Int J Epidemiol 2005; 34:121-30. (Pubitemid 40347381)
5. Shepard CW, Finelli L, Alter MJ. Global epidemiology of hepatitis C virus infection. Lancet Infect Dis 2005; 5:558-67. (Pubitemid 41196755)
6. Ghany MG, Strader DB, Thomas DL, Seeff LB. Diagnosis, management, and treatment of hepatitis C: an update. Hepatology 2009; 49: 1335-74.
7. Strader DB. Coinfection with HIV and hepatitis C virus in injection drug users and minority populations. Clin Infect Dis 2005; 41(suppl 1): S7-13.
8. Benhamou Y, Bochet M, Di Martino V, et al. Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group. Hepatology 1999; 30:1054-8. (Pubitemid 29458296)
9. Brau N, Salvatore M, Rios-Bedoya CF, et al. Slower fibrosis progression in HIV/HCV-coinfected patients with successful HIV suppression using antiretroviral therapy. J Hepatol 2006; 44:47-55. (Pubitemid 41772515)
10. Sterling RK, Wegelin JA, Smith PG, et al. Similar progression of fibrosis between HIV/HCV-infected and HCV-infected patients: analysis of paired liver biopsy samples. Clin Gastroenterol Hepatol 2010; 8: 1070-6.
11. Sterling RK SR, Luketic VA, Sanyal AJ, et al. A comparison of the spectrum of chronic hepatitis C virus between Caucasians and African Americans. Clin Gastroenterol Hepatol 2004; 2:469-73. (Pubitemid 38698361)
12. Conjeevaram HS, Fried MW, Jeffers LJ, et al. Peginterferon and ribavirin treatment in African American and Caucasian American patients with hepatitis C genotype 1. Gastroenterology 2006; 131:470-7. (Pubitemid 44142464)
13. Matthews-Greer JM, Caldito GC, Adley SD, et al. Comparison of hepatitis C viral loads in patients with or without human immunodeficiency virus. Clin Diagn Lab Immunol 2001; 8:690-4. (Pubitemid 32613692)
14. Jennings CL, Sherman KE. Hepatitis C and HIV co-infection: new drugs in practice and in the pipeline. Curr HIV/AIDS Rep 2012; 9:231-7.